Department of Gastroenterology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):8830-8836. doi: 10.26355/eurrev_202009_22822.
Long non-coding RNA (lncRNA) HMGA1P4 has been previously reported to be upregulated in gastric cancer (GC). This study aims to investigate the role of HMGA1P4 in cisplatin (DDP)-resistant GC.
HMGA1P4 levels in DDP-resistant GC tissues and cells were determined. Regulatory effects of HMGA1P4 on proliferative and apoptotic abilities in DDP-resistant GC cells and their parental cells were assessed. At last, expression levels of genes associated with multidrug-resistance (MDR) (MDR1, MRP1, mTOR and HIF-1α) and apoptosis (Bax, Bcl-2 and Caspase3) were determined in DDP-resistant GC cells.
Results revealed that HMGA1P4 was upregulated in DDP-resistant GC tissues and cells. Overexpression of HMGA1P4 stimulated proliferative rate and suppressed apoptosis in both DDP-resistant GC cells and their parental cells. Moreover, in DDP-resistant GC cells, overexpression of HMGA1P4 upregulated MDR-related genes and downregulated apoptosis-related genes.
HMGA1P4 is upregulated in DDP-resistant GC tissues and cells, and triggers the progression of DDP-resistance in GC.
长链非编码 RNA(lncRNA)HMGA1P4 先前已被报道在胃癌(GC)中上调。本研究旨在探讨 HMGA1P4 在顺铂(DDP)耐药 GC 中的作用。
检测 DDP 耐药 GC 组织和细胞中的 HMGA1P4 水平。评估 HMGA1P4 对 DDP 耐药 GC 细胞及其亲本细胞增殖和凋亡能力的调节作用。最后,检测 DDP 耐药 GC 细胞中与多药耐药(MDR)(MDR1、MRP1、mTOR 和 HIF-1α)和凋亡(Bax、Bcl-2 和 Caspase3)相关的基因表达水平。
结果表明,HMGA1P4 在 DDP 耐药 GC 组织和细胞中上调。HMGA1P4 的过表达刺激了 DDP 耐药 GC 细胞及其亲本细胞的增殖率,并抑制了凋亡。此外,在 DDP 耐药 GC 细胞中,HMGA1P4 的过表达上调了 MDR 相关基因,下调了凋亡相关基因。
HMGA1P4 在 DDP 耐药 GC 组织和细胞中上调,并引发 GC 中 DDP 耐药的进展。